Samco Small Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio predominantly consisting of equity and equity related instruments of small cap companies.
Growthvine rating: 1/5 — ranked #36 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹11.53 (as of 2026-08-21) |
|---|
| AUM | ₹159 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Umeshkumar Mehta |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | -12.14% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 90.2% of NIFTY Smallcap 250's upside and 79.8% of its downside.
Market cap allocation
| Large cap | 0.0% |
|---|
| Mid cap | 7.0% |
|---|
| Small cap | 93.0% |
|---|
Concentration
| Top 5 holdings | 17.0% |
|---|
| Top 10 holdings | 30.9% |
|---|
| Total holdings | 79 |
|---|
| Index overlap | 18.3% |
|---|
| Active share | 81.7% |
|---|
Top holdings
- Clearing Corporation of India Ltd — 17.8%
- Kirloskar Oil Engines Limited — 3.6%
- Anand Rathi Wealth Limited — 3.5%
- Navin Fluorine International Limited — 3.4%
- Ather Energy Limited — 3.3%
- Gland Pharma Limited — 3.2%
- Syrma SGS Technology Limited — 3.1%
- R R KABEL LIMITED — 3.0%
- Honasa Consumer Limited — 2.6%
- Craftsman Automation Limited — 2.6%
Top sectors
- Derivatives — 22.5%
- Industrial Products — 16.0%
- Pharma & Biotech — 11.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 15.1% | Q2 | #17 of 34 |